Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!
April 17, 2025

UDR

UDR (UDR) Stock – Investors' Brief Update

More and more people are talking about UDR over the last few weeks. Is it worth buying the Specialty Real Estate Investment Trust stock at a price of $39.46? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • UDR has moved 10.1% over the last year, and the S&P 500 logged a change of 6.0%

  • UDR has an average analyst rating of buy and is -14.64% away from its mean target price of $46.23 per share

  • Its trailing earnings per share (EPS) is $0.26

  • UDR has a trailing 12 month Price to Earnings (P/E) ratio of 151.8 while the S&P 500 average is 29.3

  • Its forward earnings per share (EPS) is $0.47 and its forward P/E ratio is 84.0

  • The company has a Price to Book (P/B) ratio of 3.84 in contrast to the S&P 500's average ratio of 4.74

  • UDR is part of the Real Estate sector, which has an average P/E ratio of 31.12 and an average P/B of 2.15

  • The company has a free cash flow of $741.04 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • UDR, Inc. (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate properties in targeted U.S. markets. As of September 30, 2024, UDR owned or had an ownership position in 60,123 apartment homes. For over 52 years, UDR has delivered long-term value to shareholders, the best standard of service to residents and the highest quality experience for associates.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS